跳至主要内容
临床试验/CTRI/2019/08/020629
CTRI/2019/08/020629已完成未知

An Observational, Cross sectional Study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients in India - H F Registry

AstraZeneca Pharma India Ltd0 个研究点目标入组 621 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
621

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Both men and women aged = 18 years
  • 2.Diagnosed with type 2 diabetes (as per ADA Criteria [Annexure 1])
  • 3.Duration of diabetes for 1 year or more
  • 4.Willing to provide written informed consent

排除标准

  • 1.Patients with evidence of coronary artery disease – CAD (based on the clinical expertise of the physician)
  • 2.Patients who were previously diagnosed with heart failure
  • 3. Patients with evidence of valvular disease based on clinical judgement of the Principle Investigator (PI).
  • 4.Current treatment with digoxin
  • 5.History or symptoms of peripheral artery disease, chronic obstructive pulmonary disease and arrhythmias
  • 6.Patients diagnosed with stage III/IV Chronic Kidney Disease (CKD)
  • 7.Diabetes other than type 2 diabetes mellitus

研究者

相似试验